Back
Revolution Medicines Inc (RVMD)
BiotechnologyRVMD · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$186.83
−2.29%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$-5.95
ROE
-76.7%
Gross margin
0.0%
Debt/Equity
0.29x
Revenue growth
P/B ratio
Beta
Forward P/E
Revolution Medicines Inc — company intelligence
Earnings surprises
Q1 2026$-2.29 vs $-1.88 est-22.1%
Q4 2025$-1.86 vs $-1.61 est-15.4%
Q3 2025$-1.61 vs $-1.45 est-11.2%
Q2 2025$-1.31 vs $-1.16 est-12.8%
Insider activity · 90 days
14 buys33 sellsnet -244,984 shares
Patel SushilSell 1,100 · Jun 29, 2026
Patel SushilSell 900 · Jun 29, 2026
Patel SushilSell 881 · Jun 29, 2026
Recent SEC filings
4 — Insider transaction reportJul 1, 2026
4 — Insider transaction reportJun 26, 2026
4 — Insider transaction reportJun 23, 2026
Latest news
HC Wainwright & Co. Reiterates Buy on Revolution Medicines, Maintains $195 Price Target — Benzinga · 5d ago
Mizuho Maintains Outperform on Revolution Medicines, Raises Price Target to $215 — Benzinga · 5d ago
Wedbush Maintains Outperform on Revolution Medicines, Raises Price Target to $181 — Benzinga · 1w ago
10 Health Care Stocks With Whale Alerts In Today’s Session — Benzinga · 1w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Revolution Medicines Inc
Weekly undervalued picks (like RVMD)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.